Search

everythinglearnresearchcommunity

for

Search:↓

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Certain medications can reduce sexual desire and function, especially in women.

Female hair loss patients more likely to have dry eye and gland issues.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Finasteride may effectively treat female pattern hair loss.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Nonandrogenic factors like oxidative stress and microinflammation are important in hair loss progression.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Androgens can both increase body hair and cause scalp hair loss.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.